Biomaterials Market size was valued at USD 139.99 Billion in 2022, accounting for a CAGR growth of 13.7% during the forecast period (2023-2030), and the market is projected to be valued at USD 390.09 Billion by 2030.
Biomaterials are substances that are designed to interact with living systems, including biological tissues, cells, and fluids. Biomaterials are derived from nature or synthesized in the laboratory using metallic components, polymers, ceramics, or composite materials. Each material has unique properties that make it suitable for different applications. For instance, biomaterials are used to design medical devices which are used to replace or augment a natural function such as heart valves, hip replacements, and others. Furthermore, metals are often used in orthopedic implants, ceramics in dental implants, and polymers in drug delivery systems.
Key market players undergo collaboration in the biomaterials industry to develop novel materials for medical devices, specifically bone adhesives, to address the need for safer, less invasive, and more cost-effective surgical procedures. For instance, in September 2020, DSM and PBC Biomed partnered to jointly design and develop novel materials for medical devices, with an initial focus on bone adhesives through PBC Biomeds affiliate, Biomimetic Innovations, to provide safer, less invasive, and cost-effective surgical procedures. Moreover, Asia Pacific is expected to be the fastest-growing region in the biomaterials market during the forecast period. The growth is attributed to the increasing prevalence of chronic diseases in the region, such as cardiovascular diseases, diabetes, and cancer. These diseases require medical interventions that often involve the use of biomaterials, such as stents, implants, and drug delivery systems, among others which led to rising demand for biomaterials.
Biomaterials Market Report Coverage:
Report Attributes
Report Details
Study Timeline
2017-2030
Market Size in 2030 (USD Billion)
390.09 Billion
CAGR (2023-2030)
13.7 %
Base Year
2022
By Material Type
Metals Biomaterials (Stainless Steel, Titanium Alloys, Cobalt Alloys, and Others (Gold, Silver, and Magnesium)), Ceramics Biomaterials (Zirconia Ceramics, Calcium Phosphate, and Others), Polymers Biomaterials (Polyester, Polyethylene, Polypropylene, Polymethyl Methacrylate, and Others), and Natural Biomaterials (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, and Others)
By Application
Orthopedic Implants (fixation (Bone Plates, Screws, Pins, Roads, and Others), Artificial Joints, Artificial Spines, Joint Replacements (Knee Replacement, Shoulder Replacement, and Others), Synthetics Bone Grafts, and Others), Dental Implants (Dental Implants, Dental Bone Grafts, and Others), Cardiovascular Devices (Catheters, Stents, Implantable Cardiac Defibrillators, Vascular Grafts, and Others), Wound Care, Tissue Engineering, Drug Delivery Systems, and Others (Hearing Loss Implants, Devices that Stimulate Nerves)
By Geography
Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey]
North America [United States, Canada, Mexico]
Middle East & Africa [GCC, North Africa, South Africa]
South America [Brazil, Argentina, Columbia, Chile, Peru]
The rising incidence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, created a significant demand for biomaterials. Furthermore, biomaterials are increasingly used in medical applications such as drug delivery systems, tissue engineering, and implants. For instance, in drug delivery systems, biomaterials are used to encapsulate drugs and control their release, which improves drug efficacy and reduces side effects. In tissue engineering, biomaterials are used as scaffolds to support the growth of new tissue, such as bone or cartilage, which are used to repair damaged or diseased tissue. All these above-mentioned factors are driving the demand for the biomaterials market.
Restraint:
• Biomaterials should meet rigorous safety and efficacy standards before they are approved for use in medical applications. This is a significant barrier to entry for smaller companies and further limits the speed of innovation in the field. Hence, market growth is restricted due to stringent regulatory requirements.
• Some biomaterials are derived from animal sources which raise ethical concerns among some patients and healthcare providers. Hence, market growth is limited due to these rising ethical concerns.
Opportunities:
The growing demand for minimally invasive surgical procedures, which require smaller incisions and less recovery time, presents opportunities for the development of biomaterials that can be used in these procedures. Furthermore, advances in biomaterials technology, combined with developments in genomics and personalized medicine, present opportunities for the development of customized biomaterials that can be tailored to an individuals unique needs.
Market Segmentation:
By Material Type
The material type segment is categorized into metals biomaterials (stainless steel, titanium alloys, cobalt alloys, and others (gold, silver, and magnesium)), ceramics biomaterials (zirconia ceramics, calcium phosphate, and others), polymers biomaterials (polyester, polyethylene, polypropylene, polymethyl methacrylate, and others), and natural biomaterials (hyaluronic acid, collagen, gelatin, fibrin, cellulose, and others). In 2022, the polymers biomaterial segment accounted for the highest market share in the biomaterials market, because polymers are widely used in medical devices and implants due to their favorable properties such as biocompatibility, ease of manufacturing, and cost-effectiveness.
However, ceramics biomaterial is expected to be the fastest-growing segment in the market over the forecast period. This is because ceramics have excellent biocompatibility and mechanical properties, which make them suitable for use in various medical applications, including dental and orthopedic implants.
By Application
The application segment is categorized into orthopedic implants (fixation (bone plates, screws, pins, roads, and others), artificial joints, artificial spines, joint replacements (knee replacement, shoulder replacement, and others), synthetics bone grafts, and others), dental implants (dental implants, dental bone grafts, and others), cardiovascular devices (catheters, stents, implantable cardiac defibrillators, vascular grafts, and others), wound care, tissue engineering, drug delivery systems, and others (hearing loss implants, devices that stimulate nerves). The orthopedic implants segment accounted for the highest market share in 2022. The growth of this segment is due to the increasing prevalence of bone and joint disorders such as osteoporosis, arthritis, and injuries related to sports and accidents.
Moreover, the rising incidence of cardiovascular diseases such as coronary artery disease, heart failure, and hypertension is driving the demand for cardiovascular devices such as stents, catheters, and implantable cardiac defibrillators. Hence, cardiovascular devices are expected to be the fastest-growing segment during the forecast period.
By Region
By region, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the highest market share in the Biomaterials market. This is attributed to factors such as the presence of a large number of key market players, well-established healthcare infrastructure, and high healthcare expenditure. Additionally, the increasing demand for advanced medical treatments and the rising prevalence of chronic diseases are driving growth in the region.
However, Asia-Pacific is expected to be the fastest-growing region in the market during the forecast period, due to the increasing aging population, the rising prevalence of chronic diseases, and the growing demand for advanced medical treatments. Additionally, government initiatives to promote the development of biomaterials and investments by key market players in the region are expected to further boost growth.
Biomaterials Market Competitive Landscape:
The biomaterials market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-
• Medtronic plc.
• Johnson & Johnson
• DSM N.V.
• Evonik Industries AG
• Dentsply Sirona
• Corbion N.V.
• Berkeley Advanced Biomaterials, Inc.
• Invibio Ltd.
• Stryker Corporation
• Covalon Technologies Ltd.
Recent Developments:
• In July 2021, Maxx Orthopedics and Invibio Biomaterial Solutions initiated a feasibility study to evaluate the safety and effectiveness of their new all-polymer femoral knee component for primary total knee arthroplasty. The study aims to assess the products market potential.
• In December 2020, Evonik Industries AG completed its acquisition of DURECT Corporations LACTEL Absorbable Polymers product line. Further, all LACTEL employees accepted offers to join Evonik in similar roles, ensuring a smooth transition.
Table of Content
1.Introduction
1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Biomaterials
1.5.Global Biomaterials Market: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in Brief
1.9.Parent Market Overview
1.10. Overall Biomaterials Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average Primary Breakdown Ratio
2.Market Dynamics
2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact Forces on Market Dynamics
2.3.2.Impact Forces During the Forecast Years
2.4.Industry Value Chain
2.4.1.Upstream Analysis
2.4.2.Downstream Analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Porter\'s Analysis
2.9.1.Supplier Power
2.9.2.Buyer Power
2.9.3.Substitution Threat
2.9.4.Threat from New Entry
2.9.5.Competitive Rivalry
2.10. PESTEL Analysis
2.11. Political Factors
2.12. Economic Factors
2.13. Social Factors
2.14. Technological Factors
2.15. Environmental Factors
2.16. Legal Factors
4.1. North America Biomaterials Market Volume (Kilograms) & Revenue (USD Billion), by Countries, (2023-2030)
4.1.1. US
4.1.1.1.By Material Type
4.1.1.2.By Application
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Biomaterials Market Volume (Kilograms) & Revenue (USD Billion), by Countries, (2023-2030)
4.2.1.Germany
4.2.2.France
4.2.3.UK
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Biomaterials Market Volume (Kilograms) & Revenue (USD Billion), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASEAN
4.4.Latin America Biomaterials Market Volume (Kilograms) & Revenue (USD Billion), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Propanol Market Volume (Kilograms) & Revenue (USD Billion), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa
5.1.Key Strategies by Players
5.2.Revenue (USD Billion and %), By Manufacturers, 2022
5.3.Player Positioning by Market Players, 2022
6.Competitive Analysis
6.1.Medtronic plc.
6.1.1.Business Overview
6.1.2.Business Financials (USD Billion)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.SWOT Analysis
6.2.Johnson & Johnson
6.3.DSM N.V.
6.4.Evonik Industries AG
6.5.Dentsply Sirona
6.6.Corbion N.V.
6.7.Berkeley Advanced Biomaterials, Inc.
6.8.Invibio Ltd.
6.9.Stryker Corporation
6.10.Covalon Technologies Ltd.
7.Market Research Findings & Conclusion
Disclaimer
Disclaimer
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
